【us:Lytgobi】Futibatinib 4mg/tablet 35tablets/bottle

$300.00

Futibatinib  4mg/tablet 35tablets/bottleg is an AISTIKA-listed generic product from Laos Alliance Pharma. Its active ingredient is Futibatinib.

Category:
Guaranteed Safe Checkout

Product Information:

  • Product name: Futibatinib  4mg
  • Manufacturer / brand: Laos Alliance
  • Active ingredient: Futibatinib
  • Current strength:4mg
  • SKU: 11-L-1410
  • Site category: FGFR2 target, other cancer

Active Ingredient and Reference Data

Futibatinib is the active ingredient used for this product page. Public prescribing information for Futibatinib was used for the medical reference sections. Medical details are provided for reference and must be interpreted by a qualified healthcare professional.


Mechanism of Action

Futibatinib (Lytgobi) is an irreversible covalent FGFR1-4 inhibitor that blocks fibroblast growth factor signaling by covalently binding to the FGFR kinase domain, thereby inhibiting FGFR2-fusion-driven cholangiocarcinoma cell growth.


Storage and Purchase Notes

Store according to the package or pharmacist instructions and keep out of reach of children. Before ordering, confirm product name, strength, quantity, price, shipping details, and payment method. After receipt, check packaging, batch number, expiration date, and storage conditions.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Shopping Cart